The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products once we have left the EU.<\/p>
The Department, as part of our EU exit preparations, has analysed the supply chains of over 12,000 licensed medicines used by patients in the United Kingdom and close to half a million product lines of medical devices and clinical consumables with an EU/European Economic Area touchpoint. This approach means that the medicines and medical equipment used by people living with disabilities are included within our planning.<\/p>
We continue to implement a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:<\/p>
https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans<\/a>.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
, "dateOfAnswer" : {"_value" : "2019-10-22", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-10-22T15:31:09.83Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-10-17", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Health Services: Disability"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the risks posed to people living with disabilities by a lack of availability of (a) medicines and (b) essential medical equipment in the event of the UK leaving the EU without a withdrawal agreement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"}
}
, "tablingMemberConstituency" : {"_value" : "North Norfolk"}
, "tablingMemberPrinted" : [{"_value" : "Norman Lamb"}
], "uin" : "1607"}
, {"_about" : "http://data.parliament.uk/resources/1150353", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1150353/answer", "answerText" : {"_value" : " All paediatric audiology services are required to record paediatric screening, assessment data, diagnosis and treatment data onto the national online database called \u2018Smart for hearing\u2019. This is co-ordinated centrally by the Newborn Hearing Screening team in the National Screening Office at Public Health England.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
}
, "answeringMemberConstituency" : {"_value" : "Gosport"}
, "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"}
, "dateOfAnswer" : {"_value" : "2019-10-24", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-10-24T11:46:52.85Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-10-17", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Hearing Impairment: Children"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether audiology Departments are required to collect data on the number of children identified as having hearing loss.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/350", "label" : {"_value" : "Biography information for Sir John Hayes"}
}
, "tablingMemberConstituency" : {"_value" : "South Holland and The Deepings"}
, "tablingMemberPrinted" : [{"_value" : "Sir John Hayes"}
], "uin" : "1546"}
, {"_about" : "http://data.parliament.uk/resources/1150376", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1150376/answer", "answerText" : {"_value" : " The National Health Service is working with Genomics England to ensure the security of personal data created by genomic sequencing through the new pipeline for Whole Genome Sequencing in the NHS.<\/p> <\/strong><\/p> Genomics England has adopted a multi-layered approach to delivering cyber security and data protection for data generated from sequencing. The approach ensures that Genomics England data capture systems remain secure and are appropriately protected from external threats. Genomics England has engaged with the Department, NHS Digital and the National Cyber Security Centre to review the Genomics England Security Strategy and Policy and is working towards formal Cyber Security Accreditation during 2020.<\/p> <\/strong><\/p> In April 2018, the Department launched the Data Security and Protection Toolkit. This covers the key data security and data protection requirements for health and social care organisations. Organisations can self-assess against it to demonstrate that they are meeting information governance requirements.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
}
, "answeringMemberConstituency" : {"_value" : "Gosport"}
, "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"}
, "dateOfAnswer" : {"_value" : "2019-10-24", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-10-24T15:10:12.713Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-10-17", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Genomics: Data Protection"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the security of personal data created by genomic sequencing.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/373", "label" : {"_value" : "Biography information for Sir David Davis"}
}
, "tablingMemberConstituency" : {"_value" : "Haltemprice and Howden"}
, "tablingMemberPrinted" : [{"_value" : "Mr David Davis"}
], "uin" : "1561"}
, {"_about" : "http://data.parliament.uk/resources/1150388", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1150388/answer", "answerText" : {"_value" : " The England Infected Blood Support Scheme (EIBSS) currently makes provision for ex gratia<\/em> one-off payments to eligible spouses, civil partners and long-term partners for individuals meeting qualifying criteria.<\/p> <\/p> The EIBSS also makes provision to help with the costs of bringing up children of an infected beneficiary in the form of an income top-up payment. This is a discretionary monthly payment to increase household income to help with general living costs. These are means-tested payments for dependants who are defined as children of an infected beneficiary up to the age of 18 years, or up to 21 if in full-time education.<\/p> <\/p> In July 2017 the then Prime Minister announced the establishment of the Infected Blood Enquiry. This statutory inquiry chaired by Sir Brian Langstaff, will examine why men, women and children in the United Kingdom were given infected blood and/or infected blood products and the impact on their families. The Inquiry will consider the nature and the adequacy of the treatment, care and support (including financial assistance) and the Government will carefully consider any recommendations made.<\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1481", "label" : {"_value" : "Biography information for Ms Nadine Dorries"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Bedfordshire"}
, "answeringMemberPrinted" : {"_value" : "Ms Nadine Dorries"}
, "dateOfAnswer" : {"_value" : "2019-10-24", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-10-24T15:47:42.777Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-10-17", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Blood: Contamination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, for what reasons parents and children of people who have died after being infected by contaminated blood products do not receive on-going financial support.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4673", "label" : {"_value" : "Biography information for Jo Platt"}
}
, "tablingMemberConstituency" : {"_value" : "Leigh"}
, "tablingMemberPrinted" : [{"_value" : "Jo Platt"}
], "uin" : "1790"}
, {"_about" : "http://data.parliament.uk/resources/1150408", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1150408/answer", "answerText" : {"_value" : " The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients throughout the United Kingdom that our plans should ensure the uninterrupted supply of medicines and medical products, including those for use in the treatment of epilepsy, once we have left the EU.<\/p> The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:<\/p>